PRF is delighted to welcome eight leading pain researchers as new science advisors. Joining the panel for a two-year term are:
- David Bennett, University of Oxford, UK
- M. Catherine Bushnell, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, US
- Howard Fields, University of California, San Francisco, US
- Ru-Rong Ji, Duke University Medical Center, Durham, North Carolina, US
- Eija Kalso, University of Helsinki, Finland
- Ted Price, University of Texas at Dallas, US
- Frank Porreca, University of Arizona, Tucson, US
- Claudia Sommer, University of Würzburg, Germany
The new advisors join returning board members Allan Basbaum, University of California, San Francisco, US; Kathleen Foley, Memorial Sloan Kettering Cancer Center, New York, US; Joseph Martin, Harvard Medical School, Boston, US; Jeffrey Mogil, McGill University, Montreal, Canada; Anne Louise Oaklander, Harvard Medical School and Massachusetts General Hospital, Boston, US; and Clifford Woolf, Boston Children’s Hospital and Harvard Medical School, Boston, US.
PRF thanks departing advisors Marshall Devor, Hebrew University of Jerusalem, Israel; Christopher Eccleston, University of Bath, UK; Rohini Kuner, University of Heidelberg, Germany; Stephen McMahon, King’s College London, UK; and William Schmidt, NorthStar Consulting, Davis, California, US. Their counsel helped make PRF the thriving Web community it is today.
PRF science advisors are among the pain field’s foremost investigators from around the world and play a critical role by providing intellectual guidance that helps shape the content of the site, including news, commentary, and forums. PRF science advisors also help identify and develop new features and resources that will expand the reach and usefulness of the site.
The editors at PRF look forward to working together with the Science Advisory Board this year to grow the only Web community devoted exclusively to pain research and to advance the new ideas and collaborative thinking that will lead to new treatments for patients suffering from chronic pain.
For more about PRF’s new and continuing board members, visit our Advisors page.
Image credit: © Ilynxv | Dreamstime.com